We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
TIDMGSK
RNS Number : 7388T
GlaxoSmithKline PLC
16 October 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Ms E Walmsley === ======================== ================================================ b) Position/status Chief Executive Officer === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 October 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) ---------- -------------------------------- GBP15.275 75.595 (personal contribution) ---------- -------------------------------- GBP15.275 187.204 (personal contribution) ---------- -------------------------------- GBP15.275 203.821 (personal contribution) ---------- -------------------------------- GBP15.275 75.595 (personal contribution) ---------- -------------------------------- GBP15.275 187.191 (personal contribution) ---------- -------------------------------- GBP15.275 203.809 (personal contribution) ---------- -------------------------------- GBP15.275 75.595 (matching shares) ---------- -------------------------------- GBP15.275 187.204 (matching shares) ---------- -------------------------------- GBP15.275 203.821 (matching shares) ---------- -------------------------------- GBP15.275 75.595 (matching shares) ---------- -------------------------------- GBP15.275 187.191 (matching shares) ---------- -------------------------------- GBP15.275 203.809 (matching shares) ---------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 1,866.43 GBP15.275 === ======================== ================================================ e) Date of the transaction 2017-10-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr R G Connor === ======================== ================================================ b) Position/status President, Global Manufacturing & Supply === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 October 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) ---------- -------------------------------- GBP15.275 55.361 (personal contribution) ---------- -------------------------------- GBP15.275 127.190 (personal contribution) ---------- -------------------------------- GBP15.275 106.128 (personal contribution) ---------- -------------------------------- GBP15.275 55.361 (personal contribution) ---------- -------------------------------- GBP15.275 106.115 (personal contribution) ---------- -------------------------------- GBP15.275 55.361 (matching shares) ---------- -------------------------------- GBP15.275 127.19 (matching shares) ---------- -------------------------------- GBP15.275 106.128 (matching shares) ---------- -------------------------------- GBP15.275 55.361 (matching shares) ---------- -------------------------------- GBP15.275 106.115 (matching contribution) ---------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 900.310 GBP15.275 === ======================== ================================================ e) Date of the transaction 2017-10-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr L Debruyne === ======================== ================================================ b) Position/status President, Global Vaccines === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================
3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 October2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) ---------- -------------------------------- GBP15.275 178.377 (personal contribution) ---------- -------------------------------- GBP15.275 178.365 (personal contribution) ---------- -------------------------------- GBP15.275 178.377 (matching shares) ---------- -------------------------------- GBP15.275 178.365 (matching shares) ---------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 713.484 GBP15.275 === ======================== ================================================ e) Date of the transaction 2017-10-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr S Dingemans === ======================== ================================================ b) Position/status Chief Financial Officer === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 October 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) ---------- -------------------------------- GBP15.275 105.590 (personal contribution) ---------- -------------------------------- GBP15.275 247.218 (personal contribution) ---------- -------------------------------- GBP15.275 185.166 (personal contribution) ---------- -------------------------------- GBP15.275 105.576 (personal contribution) ---------- -------------------------------- GBP15.275 247.205 (personal contribution) ---------- -------------------------------- GBP15.275 185.166 (personal contribution) ---------- -------------------------------- GBP15.275 105.590 (matching shares) ---------- -------------------------------- GBP15.275 247.218 (matching shares) ---------- -------------------------------- GBP15.275 185.166 (matching shares) ---------- -------------------------------- GBP15.275 105.576 (matching shares) ---------- -------------------------------- GBP15.275 247.205 (matching shares) ---------- -------------------------------- GBP15.275 185.166 (matching shares) ---------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 2,151.842 GBP15.275 === ======================== ================================================ e) Date of the transaction 2017-10-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr N Hirons === ======================== ================================================ b) Position/status SVP, Global Ethics & Compliance === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 October2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) ---------- ------------------------------- GBP15.275 38.762 (personal contribution) ---------- ------------------------------- GBP15.275 91.407 (personal contribution) ---------- ------------------------------- GBP15.275 67.081 (personal contribution) ---------- ------------------------------- GBP15.275 38.762 (personal contribution) ---------- ------------------------------- GBP15.275 91.407 (personal contribution) ---------- ------------------------------- GBP15.275 67.068 (personal contribution) ---------- ------------------------------- GBP15.275 38.762 (matching shares)
---------- ------------------------------- GBP15.275 91.407 (matching shares) ---------- ------------------------------- GBP15.275 67.081 (matching shares) ---------- ------------------------------- GBP15.275 38.762 (matching shares) ---------- ------------------------------- GBP15.275 91.407 (matching shares) ---------- ------------------------------- GBP15.275 67.068 (matching shares) ---------- ------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 788.974 GBP15.275 === ======================== ================================================ e) Date of the transaction 2017-10-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================= a) Name Mr B McNamara === ======================== =============================================== b) Position/status CEO, GSK Consumer Healthcare === ======================== =============================================== c) Initial notification/ Initial notification amendment === ======================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================= a) Name GlaxoSmithKline plc === ======================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ======================== =============================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 12 October 2017 on ADSs held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ------------------------------- $41.020 75.963 (personal contribution) --------- ------------------------------- $41.020 75.963 (matching shares) --------- ------------------------------- === ======================== =============================================== d) Aggregated information Aggregated volume Price 151.926 $41.020 === ======================== =============================================== e) Date of the transaction 2017-10-12 === ======================== =============================================== f) Place of the n/a transaction === ======================== =============================================== 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr D S Redfern === ======================== ================================================ b) Position/status Chief Strategy Officer === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 October 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) ---------- -------------------------------- GBP15.275 62.115 (personal contribution) ---------- -------------------------------- GBP15.275 116.331 (personal contribution) ---------- -------------------------------- GBP15.275 84.422 (personal contribution) ---------- -------------------------------- GBP15.275 62.115 (personal contribution) ---------- -------------------------------- GBP15.275 116.331 (personal contribution) ---------- -------------------------------- GBP15.275 84.409 (personal contribution) ---------- -------------------------------- GBP15.275 62.115 (matching shares) ---------- -------------------------------- GBP15.275 116.331 (matching shares) ---------- -------------------------------- GBP15.275 84.422 (matching shares) ---------- -------------------------------- GBP15.275 62.115 (matching shares) ---------- -------------------------------- GBP15.275 116.331 (matching shares) ---------- -------------------------------- GBP15.275 84.409 (matching shares) ---------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 1,051.446 GBP15.275 === ======================== ================================================ e) Date of the transaction 2017-10-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Ms C Thomas === ======================== ================================================ b) Position/status SVP, Human Resources === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 October 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) ---------- -------------------------------- GBP15.275 83.607 (personal contribution) ---------- -------------------------------- GBP15.275 170.189 (personal contribution) ---------- -------------------------------- GBP15.275 127.067 (personal contribution) ---------- -------------------------------- GBP15.275 83.594 (personal contribution) ---------- -------------------------------- GBP15.275 170.189 (personal contribution) ---------- -------------------------------- GBP15.275 127.067 (personal contribution) ---------- -------------------------------- GBP15.275 83.607 (matching shares) ---------- -------------------------------- GBP15.275 170.189 (matching shares) ---------- -------------------------------- GBP15.275 127.067 (matching shares) ---------- -------------------------------- GBP15.275 83.594 (matching shares) ---------- -------------------------------- GBP15.275 170.189 (matching shares) ---------- -------------------------------- GBP15.275 127.067 (matching shares) ---------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 1,523.426 GBP15.275 === ======================== ================================================ e) Date of the transaction 2017-10-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr P C Thomson === ======================== ================================================ b) Position/status President, Global Affairs === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 October 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) ---------- -------------------------------- GBP15.275 56.787 (personal contribution) ---------- -------------------------------- GBP15.275 104.127 (personal contribution) ---------- -------------------------------- GBP15.275 79.994 (personal contribution) ---------- -------------------------------- GBP15.275 56.787 (matching shares) ---------- -------------------------------- GBP15.275 104.127 (matching shares) ---------- -------------------------------- GBP15.275 79.994 (matching shares) ---------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 481.816 GBP15.275 === ======================== ================================================ e) Date of the transaction 2017-10-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================= a) Name Mr D E Troy === ======================== =============================================== b) Position/status SVP & General Counsel === ======================== =============================================== c) Initial notification/ Initial notification amendment === ======================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================= a) Name GlaxoSmithKline plc === ======================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ======================== =============================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 12 October 2017 on ADSs held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ------------------------------- $41.020 43.227 (personal contribution) --------- ------------------------------- $41.020 97.329 (personal contribution) --------- ------------------------------- $41.020 80.611 (personal contribution) --------- ------------------------------- $41.020 43.227 (personal contribution) --------- ------------------------------- $41.020 97.329 (personal contribution) --------- ------------------------------- $41.020 80.599 (personal contribution)
--------- ------------------------------- $41.020 43.227 (matching shares) --------- ------------------------------- $41.020 97.329 (matching shares) --------- ------------------------------- $41.020 80.611 (matching shares) --------- ------------------------------- $41.020 43.227 (matching shares) --------- ------------------------------- $41.020 97.329 (matching shares) --------- ------------------------------- $41.020 80.599 (matching shares) --------- ------------------------------- === ======================== =============================================== d) Aggregated information Aggregated volume Price 884.644 $41.020 === ======================== =============================================== e) Date of the transaction 2017-10-12 === ======================== =============================================== f) Place of the n/a transaction === ======================== =============================================== 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Dr P J T Vallance === ======================== ================================================ b) Position/status President, R&D === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 October 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) ---------- -------------------------------- GBP15.275 123.070 (personal contribution) ---------- -------------------------------- GBP15.275 200.197 (personal contribution) ---------- -------------------------------- GBP15.275 138.016 (personal contribution) ---------- -------------------------------- GBP15.275 123.070 (personal contribution) ---------- -------------------------------- GBP15.275 200.197 (personal contribution) ---------- -------------------------------- GBP15.275 138.016 (personal contribution) ---------- -------------------------------- GBP15.275 123.070 (matching shares) ---------- -------------------------------- GBP15.275 200.197 (matching shares) ---------- -------------------------------- GBP15.275 138.016 (matching shares) ---------- -------------------------------- GBP15.275 123.070 (matching shares) ---------- -------------------------------- GBP15.275 200.197 (matching shares) ---------- -------------------------------- GBP15.275 138.016 (matching shares) ---------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 1,845.132 GBP15.275 === ======================== ================================================ e) Date of the transaction 2017-10-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEQLFFDBFEFBF
(END) Dow Jones Newswires
October 16, 2017 11:52 ET (15:52 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions